One the nation’s top pediatric hospital engages CynergisTek for penetration testing and advisory support services
AUSTIN, Texas–(BUSINESS WIRE)–$CTEK #CTEK–CynergisTek (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, announces one of the leading pediatric and obstetric hospitals in the pacific region has signed a six-figure contract for Red Team services and advisory support. The hospital adds one thousand hours of support throughout the next year.
CynergisTek’s Red Team performs external network penetration and web application testing to evaluate the security posture of clients. These security risk assessments provide valuable insight into the effectiveness of an organization’s cybersecurity program by identifying any gaps or vulnerabilities that cybercriminals may exploit and recommending prioritized remediation steps. CynergisTek’s Remediation Support Services provide clients with advisory and hands-on support for the development and implementation of these steps to strengthen their security program maturity.
Lack of patching discipline was listed as one of the top contributors to incidents and risk in healthcare IT according to ECRI. “More and more health systems are realizing the benefits and necessity of increasing the frequency and scope of their testing activities,” said Mac McMillan, CEO of CynergisTek. “A control not tested is a control not trusted, plain and simple. The hackers are counting on organizations not testing, which is demonstrated by the high number of attacks that occur because something wasn’t patched, blocked, enabled, configured properly, you name it.”
Healthcare organizations like this west coast-based children’s hospital understand the importance of validating their security controls and processes to prevent cyberattacks and proactively looking at potential threats. The agreement allows this client to continue to rely on CynergisTek’s expertise and benefit from guidance on how to remediate vulnerabilities in their cybersecurity, privacy, compliance, and IT Audit programs.
About CynergisTek, Inc.
CynergisTek is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company’s security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or LinkedIn.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements relating to the business of CynergisTek. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company’s vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of the COVID-19 pandemic, including actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets; the general economic impact of the ongoing war in Ukraine, including the impact of related sanctions being imposed by the U.S. Government and the governments of other countries, and the impact of potential reprisals as a consequence of the war in Ukraine and any related sanctions; and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry, or the ongoing war in Ukraine. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
CynergisTek Investor Relations Contact:
(512) 402-8550 x7
CynergisTek Media Contact: